Close
ACHEMA MIDDLE EAST 2026

Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program Evaluating Ruxolitinib Cream in Patients with Vitiligo

Incyte announced that the first patient has been treated in the Phase 3 TRuE-V clinical trial program evaluating the safety and efficacy of ruxolitinib...

Zogenix Announces Acquisition of Modis Therapeutics, Inc.

Zogenix, Inc, a global pharmaceutical company developing rare disease therapies, announced that it has entered into a definitive agreement to acquire Modis Therapeutics, Inc.,...

ADC Therapeutics and Freenome Enter Biomarker Development Collaboration

ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), and Freenome, a biotechnology company...

DiscGenics Receives FDA Fast Track Designation for Cell Therapy for Disc Degeneration

 DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases...

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Bayer AG and BlueRock Therapeutics announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on...

LexaGene to Place Beta Unit in Human Clinical Diagnostics Laboratory

LexaGene Holdings, Inc. , a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced  it has an agreement...

Bosch introduces entry-level Pack 102 flow wrapper with robotic integration at IBIE

At the International Baking Industry Expo (IBIE) 2019, Bosch Packaging Technology will introduce its entry-level Pack 102 horizontal flow wrapper using a Fanuc Scara...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...